Evaluate Safety and Efficacy of a Single Treatment Cycle of EB-001 in Subjects With Glabellar Frown Lines
Phase of Trial: Phase II
Latest Information Update: 09 Oct 2017
At a glance
- Drugs Botulinum toxin E (Primary)
- Indications Glabellar lines
- Focus Adverse reactions; First in man; Proof of concept; Therapeutic Use
- Sponsors Bonti
- 09 Oct 2017 According to a Bonti media release, results were presented at Plastic Surgery The Meeting 2017 organized by the American Society of Plastic Surgeons (ASPS).
- 13 Sep 2017 According to a Bonti media release, results from this study will be presented at the American Society for Dermatological Surgery (ASDS) Annual Meeting 2017.
- 16 Aug 2017 Status changed from recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History